Investing Profile

Felice Verduyn - van Weegen

VCInvestor
Partner at EQT Life Sciences
eqtgroup.com/about/people/fel...Amsterdam, Netherlands
Photo of Felice Verduyn - van Weegen, Partner at EQT Life Sciences
Your Intro Paths to Felice Verduyn - van Weegen

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Felice Verduyn - van Weegen on

cb
Current Investing Position
EQT Life Sciences Partner
Investment Range
$11.0M - $65.0M
Sweet Spot
$25.0M
Investments On Record
7
Current Fund Size
€260M

Felice Verduyn - van Weegen is on these Sector & Stage Rankings

Felice Verduyn - van Weegen's Investments On Record (5)

CompanyStageDateRound SizeTotal Raised
Vico Therapeutics
Series BJan 2024$72M
Series AJul 2020$31M
$120M
Co-investors: Amy Schulman (Polaris Partners), Jean-François Rivassou (Kurma Partners), Rémi Droller (Kurma Partners), Martijn Kleijwegt (EQT Life Sciences), Silvia Noiman (Pontifax Venture Capital)
AgomAb Therapeutics
Series COct 2023$100M
$200M
Co-investors: Colleen Cuffaro (Canaan Partners), Ohad Hammer (Pontifax Venture Capital), Iyona Rajkomar (Pontifax Venture Capital)
Amolyt Pharma
Series CJan 2023$140M
Series BSep 2021$80M
$290M
Co-investors: Ohad Hammer (Pontifax Venture Capital), Thierry Laugel (Kurma Partners), Raphael Wisniewski (Andera Partners), Iyona Rajkomar (Pontifax Venture Capital), Cedric Moreau (Soffinova Partners)
Egle Therapeutics
Series AOct 2021$47M
$47M
Co-investors: Jacques Mizrahi (Bioqube Ventures), Vincent Brichard
AM Pharma
Series FJul 2019$130M
$210M
Co-investors: Joël Jean-Mairet (Ysios Capital), Laia Crespo (Sanofi Ventures), Rémi Droller (Kurma Partners), Martijn Kleijwegt (EQT Life Sciences), Raphael Wisniewski (Andera Partners), Geert-Jan Mulder (Forbion)